Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Jodi E. Spady, PA-C
Physician Assistant · IMPERIAL, NE · NPI 1053479089
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 569 | 96 |
| Atorvastatin Calcium | Atorvastatin Calcium | 368 | 69 |
| Losartan Potassium | Losartan Potassium | 283 | 59 |
| Furosemide | Furosemide | 252 | 38 |
| Potassium Chloride | Potassium Chloride | 227 | 40 |
| Amlodipine Besylate | Amlodipine Besylate | 224 | 46 |
| Omeprazole | Omeprazole | 223 | 45 |
| Gabapentin | Gabapentin | 198 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 196 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 191 | 35 |
| Simvastatin | Simvastatin | 190 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 188 | 42 |
| Lisinopril | Lisinopril | 175 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 36 |
| Xarelto | Rivaroxaban | 171 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 163 | 33 |
| Metformin Hcl | Metformin Hcl | 150 | 24 |
| Sertraline Hcl | Sertraline Hcl | 130 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 126 | 27 |
| Metformin Hcl Er | Metformin Hcl | 115 | 18 |
| Alendronate Sodium | Alendronate Sodium | 112 | 16 |
| Enalapril Maleate | Enalapril Maleate | 107 | 14 |
| Donepezil Hcl | Donepezil Hcl | 106 | 13 |
| Allopurinol | Allopurinol | 100 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 100 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 18 |
| Eliquis | Apixaban | 82 | 12 |
| Spironolactone | Spironolactone | 82 | 14 |
| Jardiance | Empagliflozin | 81 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 81 | 15 |
| Famotidine | Famotidine | 78 | 14 |
| Meloxicam | Meloxicam | 74 | 17 |
| Warfarin Sodium | Warfarin Sodium | 72 | suppressed |
| Carvedilol | Carvedilol | 70 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 70 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 70 | 54 |
| Benazepril Hcl | Benazepril Hcl | 68 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 68 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 67 | 13 |
| Trazodone Hcl | Trazodone Hcl | 59 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 57 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 54 | 54 |
| Pravastatin Sodium | Pravastatin Sodium | 52 | suppressed |
| Alprazolam | Alprazolam | 50 | 11 |
| Ezetimibe | Ezetimibe | 50 | 14 |
| Prednisone | Prednisone | 50 | 15 |
| Celecoxib | Celecoxib | 46 | 13 |
| Ibuprofen | Ibuprofen | 42 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 42 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 40 | suppressed |
| Synthroid | Levothyroxine Sodium | 40 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 36 | 36 |
| Azathioprine | Azathioprine | 36 | suppressed |
| Glipizide | Glipizide | 36 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 31 | 12 |
| Glipizide Er | Glipizide | 31 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Atenolol | Atenolol | 28 | suppressed |
| Baclofen | Baclofen | 28 | 12 |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 27 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Nystatin | Nystatin | 24 | suppressed |
| Pregabalin | Pregabalin | 24 | suppressed |
| Anastrozole | Anastrozole | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 22 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 22 | suppressed |
| Sucralfate | Sucralfate | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Clonazepam | Clonazepam | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 17 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 17 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 15 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Latanoprost | Latanoprost | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Sulfasalazine | Sulfasalazine | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | 11 |
| Trimethoprim | Trimethoprim | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 12 |
| Bumetanide | Bumetanide | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error